Insulin Pumps Market Research Report - Forecast till 2028

Impact of Coronavirus (covid-19) on the Global Insulin Pumps Market

COVID-19 is a respiratory disease caused due to coronavirus SARS-CoV-2. Currently, the world is facing a pandemic due to COVID-19. This pandemic has posed a significant impact on the medical device industry, as it has negatively impacted the demand for elective procedures, orthopedic medical devices, but increased the demand for protective equipment. COVID-19 has expressively increased the demand for protective equipment which includes face shields, nose masks, protective mouth, respiratory pumps, insulin devices, and protective clothing and gloves.

But the steps taken by the government to fight against the pandemic has disrupted production capabilities and supply chains dramatically, which can create a shortage of essential healthcare product in the long term. Patients with different health issues such as respiratory disease, diabetes, and high blood pressure are at higher risk of getting affected by this virus. It is found that the mortality rate is high in a patient with diabetes compared to the general population. The people living having diabetes require continuous access to essential medicines, technologies, and care. Without or irregular supply of insulin devices or technologies a person with diabetes will die within a few days. To overcome this situation the insulin manufacturing companies are taking different steps to make the product available to the patients.

The companies are trying to supply the essential healthcare products through different modes such as online portal, hospital pharmacies, and emergency medical stores. For instance, Medtronic has provided an online shopping website for diabetes products to make supply orders easier. Additionally, in March 2020, Tandem Diabetes Care, Inc. stated that there are no shortages of insulin pumps and its supplies. By understanding the current situation with COVID-19 and increased need for remote options to help manage our health. Tandem has also developed a reminder app “t:connect” through which the healthcare provider, can review the pump data and guide the patient.  

Company Statements Regarding COVID-19 Impact

• BD one of the leading medical device company stated that its manufacturing and distribution centers across the globe are working normally and that in European countries such as Spain, Italy, Ireland, and France, where there is a strict lockdown have been imposed, the has taken proper measures to ensure business continuity.

• Insulet a US-based company also confirmed that there is no expected disturbance to supply and no change to the ordering process.

• Whereas, Tandem stated that its manufacturing and warehousing facilities are operating normally and that the company does not await a shortage of infusion sets, pumps, cartridges, or other supplies.